AQST

AQST

USD

Aquestive Therapeutics Inc. Common Stock

$6.040-0.370 (-5.772%)

Echtzeitkurs

Healthcare
Drug Manufacturers - Specialty & Generic
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$6.410

Hoch

$6.410

Tief

$5.790

Volumen

3.85M

Unternehmensfundamentaldaten

Marktkapitalisierung

736.9M

Branche

Drug Manufacturers - Specialty & Generic

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

3.10M

Börse

NGM

Währung

USD

52-Wochen-Spanne

Tief $2.12Aktuell $6.040Hoch $7.55

Ähnliche Nachrichten

GlobeNewswire

Aquestive Therapeutics Announces Leadership Expansion to Support Growth

Changes strategically aligned to support planned launch of Anaphylm™ (dibutepinephrine) Sublingual Film, if approved by the FDA, and to accelerate the Company's ongoing development initiatives Matthew Davis, M.D.,

Mehr anzeigen
Aquestive Therapeutics Announces Leadership Expansion to Support Growth
GlobeNewswire

Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler

WARREN, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients'

Mehr anzeigen
Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler
GlobeNewswire

Aquestive Therapeutics to Attend 2025 ACAAI Annual Meeting

WARREN, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients'

Mehr anzeigen
Aquestive Therapeutics to Attend 2025 ACAAI Annual Meeting
GlobeNewswire

Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET

WARREN, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients'

Mehr anzeigen
Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.